title: Microtubule-targeting drugs and personalization of cancer treatment.
authors.forename: Cristina
authors.initials: C
authors.lastname: Rodríguez-Antona
authors.forename: Henrik
authors.initials: H
authors.lastname: Gréen
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D016588:Anticarcinogenic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D054316:Biomarkers, Pharmacological; D065727:Cytochrome P-450 CYP2C8; D006801:Humans; D008870:Microtubules / Q000187:drug effects*; D009369:Neoplasms / Q000188:drug therapy*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D043823:Taxoids / Q000009:adverse effects / Q000627:therapeutic use; D014404:Tubulin / Q000235:genetics; D050257:Tubulin Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D014748:Vinca Alkaloids / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D016588:Anticarcinogenic Agents; D054316:Biomarkers, Pharmacological; D043823:Taxoids; D014404:Tubulin; D050257:Tubulin Modulators; D014748:Vinca Alkaloids; D001189:Aryl Hydrocarbon Hydroxylases; C450259:CYP2C8 protein, human; D065727:Cytochrome P-450 CYP2C8